Clinical Trial Detail

NCT ID NCT02307240
Title Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Curis, Inc.
Indications

breast cancer

ovarian cancer

Advanced Solid Tumor

triple-receptor negative breast cancer

NUT midline carcinoma

Therapies

CUDC-907

Age Groups: adult senior

Additional content available in CKB BOOST